The 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) is the most known positron emitter radiopharmaceutical, in both clinical and preclinical field. Starting from an analysis of the literature of the last 40 years, we have deal with several aspects concerning [18F]FDG and their evolution during the years, and discussed about the possible future perspectives of this important radiotracer.
Hystorical and Radiopharmaceutical Relevance of [18F]FDG
D Petroni;L Menichetti;M Poli
2020
Abstract
The 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) is the most known positron emitter radiopharmaceutical, in both clinical and preclinical field. Starting from an analysis of the literature of the last 40 years, we have deal with several aspects concerning [18F]FDG and their evolution during the years, and discussed about the possible future perspectives of this important radiotracer.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
